Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 437.76M
March 31, 2026 375.99M
December 31, 2025 449.88M
September 30, 2025 511.04M
June 30, 2025 459.83M
March 31, 2025 503.75M
December 31, 2024 601.52M
September 30, 2024 658.11M
June 30, 2024 691.07M
March 31, 2024 791.29M
December 31, 2023 912.22M
September 30, 2023 854.79M
June 30, 2023 908.07M
March 31, 2023 933.54M
December 31, 2022 1.193B
September 30, 2022 828.19M
June 30, 2022 874.28M
March 31, 2022 855.25M
December 31, 2021 748.69M
September 30, 2021 800.17M
June 30, 2021 529.02M
Date Value
March 31, 2021 584.06M
December 31, 2020 600.07M
September 30, 2020 407.95M
June 30, 2020 436.80M
March 31, 2020 250.26M
December 31, 2019 279.73M
September 30, 2019 285.92M
June 30, 2019 271.10M
March 31, 2019 296.58M
December 31, 2018 314.06M
September 30, 2018 293.25M
June 30, 2018 305.54M
March 31, 2018 327.78M
December 31, 2017 340.68M
September 30, 2017 222.26M
June 30, 2017 241.05M
March 31, 2017 257.55M
December 31, 2016 273.06M
September 30, 2016 290.62M
June 30, 2016 300.69M
March 31, 2016 64.19M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Beam Therapeutics, Inc. 1.153B
Twist Bioscience Corp. 166.84M
Tenaya Therapeutics, Inc. 78.08M
Moderna, Inc. 5.138B
Revolution Medicines, Inc. 3.938B